Biomarker Testing in NSCLC: How are we doing?

As a nurse practitioner working in thoracic medical oncology, I have seen the changes in non-small cell lung cancer (NSCLC) change dramatically over the past 20 years that I have been practicing in this subspecialized field. Twenty years ago were the days of just paclitaxel and carboplatin as ...

Read More

How a Hematology Clinical Rotation Made me a Better Clinician

Starting physician assistant (PA) school certainly presented its obstacles. How would I, a fresh college graduate, be able to tackle an intense medical education within the span of 27 months? The answer was almost too simple – one semester at a time. Fifteen months of didactic education came and ...

Read More

Recent Updates in the Treatment of Chronic-Graft-Versus-Host Disease

Chronic graft-versus-host disease (cGVHD) is one of most common, yet severe, consequences of allogeneic hematopoietic stem cell transplantation. Occurring in up to 70% of patients, cGVHD is the leading cause of non-relapse mortality after allogeneic transplantation. Two new agents, belumosudil ...

Read More

Connect Today, Improve Patient Care Tomorrow!

Sign Up For the Newsletter!

Read our Latest Posts

Biomarker Testing in NSCLC: How are we doing?

How a Hematology Clinical Rotation Made me a Better Clinician

Recent Updates in the Treatment of Chronic-Graft-Versus-Host Disease

Interested in Submitting an Article? Fill Out the Form Here!

Register For an APP Oncology Summit Near You!

Don't Miss Out on our Upcoming 2022 Conferences!